IBDEI0EN ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14646,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,14646,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,14646,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,14647,0)
 ;;=D61.82^^61^740^171
 ;;^UTILITY(U,$J,358.3,14647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14647,1,3,0)
 ;;=3^Myelophthisis
 ;;^UTILITY(U,$J,358.3,14647,1,4,0)
 ;;=4^D61.82
 ;;^UTILITY(U,$J,358.3,14647,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,14648,0)
 ;;=D47.9^^61^740^172
 ;;^UTILITY(U,$J,358.3,14648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14648,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior
 ;;^UTILITY(U,$J,358.3,14648,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,14648,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,14649,0)
 ;;=D53.9^^61^740^176
 ;;^UTILITY(U,$J,358.3,14649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14649,1,3,0)
 ;;=3^Nutritional Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,14649,1,4,0)
 ;;=4^D53.9
 ;;^UTILITY(U,$J,358.3,14649,2)
 ;;=^5002298
 ;;^UTILITY(U,$J,358.3,14650,0)
 ;;=D47.4^^61^740^177
 ;;^UTILITY(U,$J,358.3,14650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14650,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,14650,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,14650,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,14651,0)
 ;;=D59.1^^61^740^28
 ;;^UTILITY(U,$J,358.3,14651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14651,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,14651,1,4,0)
 ;;=4^D59.1
 ;;^UTILITY(U,$J,358.3,14651,2)
 ;;=^5002324
 ;;^UTILITY(U,$J,358.3,14652,0)
 ;;=D51.3^^61^740^191
 ;;^UTILITY(U,$J,358.3,14652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14652,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Other
 ;;^UTILITY(U,$J,358.3,14652,1,4,0)
 ;;=4^D51.3
 ;;^UTILITY(U,$J,358.3,14652,2)
 ;;=^5002287
 ;;^UTILITY(U,$J,358.3,14653,0)
 ;;=D77.^^61^740^57
 ;;^UTILITY(U,$J,358.3,14653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14653,1,3,0)
 ;;=3^Disorder of Blood/Blood-Forming Organs in Diseases Classified Elsewhere,Other
 ;;^UTILITY(U,$J,358.3,14653,1,4,0)
 ;;=4^D77.
 ;;^UTILITY(U,$J,358.3,14653,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,14654,0)
 ;;=D58.2^^61^740^83
 ;;^UTILITY(U,$J,358.3,14654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14654,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,14654,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,14654,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,14655,0)
 ;;=C88.8^^61^740^103
 ;;^UTILITY(U,$J,358.3,14655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14655,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,14655,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,14655,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,14656,0)
 ;;=D70.8^^61^740^174
 ;;^UTILITY(U,$J,358.3,14656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14656,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,14656,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,14656,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,14657,0)
 ;;=D59.4^^61^740^175
 ;;^UTILITY(U,$J,358.3,14657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14657,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,14657,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,14657,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,14658,0)
 ;;=D69.59^^61^740^181
 ;;^UTILITY(U,$J,358.3,14658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14658,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,14658,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,14658,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,14659,0)
 ;;=C22.7^^61^740^46
 ;;^UTILITY(U,$J,358.3,14659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14659,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,14659,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,14659,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,14660,0)
 ;;=D75.89^^61^740^56
 ;;^UTILITY(U,$J,358.3,14660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14660,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,14660,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,14660,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,14661,0)
 ;;=D47.Z9^^61^740^173
 ;;^UTILITY(U,$J,358.3,14661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14661,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,14661,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,14661,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,14662,0)
 ;;=D05.82^^61^740^34
 ;;^UTILITY(U,$J,358.3,14662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14662,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,14662,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,14662,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,14663,0)
 ;;=D05.81^^61^740^36
 ;;^UTILITY(U,$J,358.3,14663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14663,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,14663,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,14663,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,14664,0)
 ;;=D05.80^^61^740^38
 ;;^UTILITY(U,$J,358.3,14664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14664,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,14664,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,14664,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,14665,0)
 ;;=D56.8^^61^740^186
 ;;^UTILITY(U,$J,358.3,14665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14665,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,14665,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,14665,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,14666,0)
 ;;=C82.89^^61^740^76
 ;;^UTILITY(U,$J,358.3,14666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14666,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,14666,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,14666,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,14667,0)
 ;;=D51.8^^61^740^193
 ;;^UTILITY(U,$J,358.3,14667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14667,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,14667,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,14667,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,14668,0)
 ;;=I80.9^^61^740^178
 ;;^UTILITY(U,$J,358.3,14668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14668,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,14668,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,14668,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,14669,0)
 ;;=D45.^^61^740^179
 ;;^UTILITY(U,$J,358.3,14669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14669,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,14669,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,14669,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,14670,0)
 ;;=C77.3^^61^740^109
 ;;^UTILITY(U,$J,358.3,14670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14670,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,14670,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,14670,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,14671,0)
 ;;=C77.2^^61^740^125
 ;;^UTILITY(U,$J,358.3,14671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14671,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,14671,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,14671,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,14672,0)
 ;;=C77.1^^61^740^126
 ;;^UTILITY(U,$J,358.3,14672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14672,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,14672,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,14672,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,14673,0)
 ;;=C77.0^^61^740^142
 ;;^UTILITY(U,$J,358.3,14673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14673,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
